Segui
Elisa Gremese
Elisa Gremese
Email verificata su unicatt.it
Titolo
Citata da
Citata da
Anno
Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial
D Khanna, CJF Lin, DE Furst, J Goldin, G Kim, M Kuwana, Y Allanore, ...
The Lancet Respiratory Medicine 8 (10), 963-974, 2020
4202020
Distinct synovial tissue macrophage subsets regulate inflammation and remission in rheumatoid arthritis
S Alivernini, L MacDonald, A Elmesmari, S Finlay, B Tolusso, MR Gigante, ...
Nature medicine 26 (8), 1295-1306, 2020
3752020
Post-COVID-19 global health strategies: the need for an interdisciplinary approach
Aging clinical and experimental research 32 (8), 1613-1620, 2020
3172020
Clinical and ultrasonographic remission determines different chances of relapse in early and long standing rheumatoid arthritis
G Peluso, A Michelutti, S Bosello, E Gremese, B Tolusso, G Ferraccioli
Annals of the rheumatic diseases 70 (1), 172-175, 2011
2462011
Jean-Charles Preiser
E Gremese, G Ferraccioli
medicine 65, 94-100, 2013
2322013
Efficacy and safety of ixekizumab in the treatment of radiographic axial spondyloarthritis: sixteen‐week results from a phase III randomized, double‐blind, placebo‐controlled …
A Deodhar, D Poddubnyy, C Pacheco‐Tena, C Salvarani, ...
Arthritis & rheumatology 71 (4), 599-611, 2019
2292019
Long-term anti-TNF therapy and the risk of serious infections in a cohort of patients with rheumatoid arthritis: comparison of adalimumab, etanercept and infliximab in the …
F Atzeni, P Sarzi-Puttini, C Botsios, A Carletto, P Cipriani, EG Favalli, ...
Autoimmunity reviews 12 (2), 225-229, 2012
1962012
MicroRNA-155—at the critical interface of innate and adaptive immunity in arthritis
S Alivernini, E Gremese, C McSharry, B Tolusso, G Ferraccioli, IB McInnes, ...
Frontiers in immunology 8, 1932, 2018
1832018
Very early rheumatoid arthritis as a predictor of remission: a multicentre real life prospective study
E Gremese, F Salaffi, SL Bosello, A Ciapetti, F Bobbio-Pallavicini, ...
Annals of the rheumatic diseases 72 (6), 858-862, 2013
1692013
Interleukin-1β and interleukin-6 in arthritis animal models: roles in the early phase of transition from acute to chronic inflammation and relevance for human rheumatoid arthritis
G Ferraccioli, L Bracci-Laudiero, S Alivernini, E Gremese, B Tolusso, ...
Molecular medicine 16, 552-557, 2010
1662010
Development and validation of a new algorithm for attribution of neuropsychiatric events in systemic lupus erythematosus
A Bortoluzzi, CA Scire, S Bombardieri, L Caniatti, F Conti, S De Vita, ...
Rheumatology 54 (5), 891-898, 2015
1602015
Obesity as a risk and severity factor in rheumatic diseases (autoimmune chronic inflammatory diseases)
E Gremese, B Tolusso, G Ferraccioli
Frontiers in immunology 5, 116166, 2014
1562014
Body weight, gender and response to TNF-α blockers in axial spondyloarthritis
E Gremese, S Bernardi, S Bonazza, M Nowik, G Peluso, A Massara, ...
Rheumatology 53 (5), 875-881, 2014
1492014
The metabolic syndrome: the crossroads between rheumatoid arthritis and cardiovascular risk
E Gremese, G Ferraccioli
Autoimmunity reviews 10 (10), 582-589, 2011
1402011
Efficacy and safety of off-label use of rituximab in refractory lupus: data from the Italian Multicentre Registry
L Iaccarino, E Bartoloni, L Carli, F Ceccarelli, F Conti, S De Vita, ...
Clinical and experimental rheumatology 33 (4), 449-456, 2015
1332015
Very early rheumatoid arthritis is the major predictor of major outcomes: clinical ACR remission and radiographic non-progression
S Bosello, AL Fedele, G Peluso, E Gremese, B Tolusso, G Ferraccioli
Annals of the rheumatic diseases 70 (7), 1292-1295, 2011
1312011
Longterm retention of tumor necrosis factor-α inhibitor therapy in a large italian cohort of patients with rheumatoid arthritis from the GISEA registry: an appraisal of predictors
F Iannone, E Gremese, F Atzeni, D Biasi, C Botsios, P Cipriani, C Ferri, ...
The Journal of rheumatology 39 (6), 1179-1184, 2012
1302012
Incidence of deep vein thrombosis among non‐ICU patients hospitalized for COVID‐19 despite pharmacological thromboprophylaxis
A Santoliquido, A Porfidia, A Nesci, G De Matteis, G Marrone, E Porceddu, ...
Journal of Thrombosis and Haemostasis 18 (9), 2358-2363, 2020
1192020
MicroRNA-155 influences B-cell function through PU. 1 in rheumatoid arthritis
S Alivernini, M Kurowska-Stolarska, B Tolusso, R Benvenuto, ...
Nature communications 7 (1), 12970, 2016
1162016
Analysis of improvements, full responses, remission and toxicity in rheumatoid patients treated with step‐up combination therapy (methotrexate, cyclosporin A, sulphasalazine …
GF Ferraccioli, E Gremese, P Tomietto, G Favret, R Damato, E Di Poi
Rheumatology 41 (8), 892-898, 2002
1102002
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20